The totally implantable venous access deviceis a blood vessel or thoracoabdominal access device that is completely implanted in the body, which can reduce the pain and risk of repeated vein, artery, thoracoabdominal puncture.
Market Analysis and Insights: Global Totally Implantable Venous Access Device Market
Due to the COVID-19 pandemic, the global Totally Implantable Venous Access Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Titanium Infusion Port accounting for % of the Totally Implantable Venous Access Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Intravenous Chemotherapy segment is altered to an % CAGR throughout this forecast period.
China Totally Implantable Venous Access Device market size is valued at US$ million in 2021, while the US and Europe Totally Implantable Venous Access Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Totally Implantable Venous Access Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Totally Implantable Venous Access Device include AngioDynamics, B. Braun Medical, Bard Access Systems, MedComp, Navilyst Medical, Norfolk Medical Products, Smiths Medical, Teleflex and Vygon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Totally Implantable Venous Access Device Scope and Segment
Totally Implantable Venous Access Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Totally Implantable Venous Access Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Titanium Infusion Port
Plastic Infusion Port
Segment by Application
Intravenous Chemotherapy
Nutritional Support Treatment
By Company
AngioDynamics
B. Braun Medical
Bard Access Systems
MedComp
Navilyst Medical
Norfolk Medical Products
Smiths Medical
Teleflex
Vygon
PFM Medical
Districlass
Fresenius
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE